This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: China's robotaxi ambitions prompt soul searching on job losses in Wuhan

By MLex Staff ( July 18, 2024, 07:43 GMT | Comment) -- The commercial use of driverless robotaxis in China’s Wuhan city has prompted a rival taxi company to appeal for more government regulatory restrictions. This, in turn, has sparked a debate about whether China’s technological ambitions should come at the expense of jobs. Beijing hasn't taken a public stance on the Wuhan drivers' outcry, but its push for self-sufficiency in cutting-edge technologies such as autonomous vehicles underscores the priority the government might place on remaining competitive with the United States in a field seen as critical for future economic growth.A recent appeal by a taxi company in China’s Wuhan city, Hubei province, to seek more government restrictions on Baidu’s Apollo Go robotaxis has sparked a nationwide debate over whether the country’s technological ambitions should come at the expense of jobs....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login